scholarly journals Prevalence of metabolic syndrome among middle-aged and elderly adults in China: current status and temporal trends

2018 ◽  
Vol 50 (4) ◽  
pp. 345-353 ◽  
Author(s):  
Wenzhen Li ◽  
Fujian Song ◽  
Xiaojun Wang ◽  
Longde Wang ◽  
Dongming Wang ◽  
...  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Bo Liu ◽  
Guanqun Chen ◽  
Ruijie Zhao ◽  
Dan Huang ◽  
Lixin Tao

Abstract Background Metabolic syndrome (MetS) is a major risk factor for cardiovascular diseases. The objective of the study was to evaluate the updated prevalence of MetS and provide a comprehensive illustration of the possible temporal changes in MetS prevalence in China from 2011 to 2015. Methods The data for this study are from the 2011 and 2015 waves of the China Health and Retirement Longitudinal Study (CHARLS). CHARLS is a nationally representative survey targeting populations aged 45 and above from 28 provinces in mainland China. A total of 11,847 and 13,013 participants were eligible for data analysis at the two time points. Results The estimated prevalence of MetS in 2015 was 20.41% (95% CI: 19.02–21.8%) by the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) criteria, 34.77% (95% CI: 33.12–36.42%) by the International Diabetes Federation (IDF) criteria, 39.68% (95% CI: 37.88–41.47%) by the revised ATP III criteria, and 25.55% (95% CI: 24.19–26.91%) by the Chinese Diabetes Society (CDS) criteria. The prevalence was higher among women and elderly adults and in urban and northern populations. Furthermore, the trends in the prevalence decreased significantly between 2011 and 2015 by the ATP III, revised ATP III and CDS criteria. However, trends increased significantly from 2011 to 2015 by the IDF criteria. Conclusions A higher prevalence of MetS is found in those who reported being middle aged and elderly, women, residing in northern China or living in urban areas. Additionally, temporal changes in the prevalence of MetS varied according to different criteria. Increased attention to the causes associated with populations who have higher levels of MetS is warranted.


Stroke ◽  
2014 ◽  
Vol 45 (suppl_1) ◽  
Author(s):  
Michael McManus ◽  
Daniela Markovic ◽  
Natalie Valle ◽  
Bruce Ovbiagele ◽  
Amytis Towfighi

BACKGROUND: Metabolic syndrome (MetS), a constellation of cardiometabolic risk factors clustering together, affects >47 million US adults and has been independently linked to primary and recurrent stroke risk. Prevalence and trends in MetS among stroke survivors in the United States are unknown. OBJECTIVES: To evaluate recent temporal trends in age and sex-specific MetS prevalence among adults with/without stroke in the US. METHODS: Prevalence of MetS was assessed among fasting adults ≥35 years who participated in National Health and Nutrition Examination Surveys 1999-2010 (n=9,343). Prevalence estimates were weighted to obtain nationally representative estimates (n=430,371,669). MetS was defined by the 2009 harmonized definition. Stroke was determined by self-report. RESULTS: In all groups except men 35-64 years, MetS prevalence was similar among adults with and without stroke in 1999-2002 (Table). MetS prevalence rates were flat from 1999 to 2010 among those without stroke, but increased among stroke survivors, such that up to 80% of men and 86% of women with stroke had MetS, with the greatest rise among the middle-aged. Stroke survivors aged 35-64 years were ~3 times more likely to have MetS than their counterparts without stroke (OR 3.24, 95% CI 1.60-6.55 for men and OR 2.55, 95% CI 1.45-4.50 for women). DISCUSSION: Due to a differential rise in MetS in stroke survivors over the last 10 years, as many as 9 out of 10 stroke survivors now have MetS, suggesting that Mets may increasingly be placing people at risk for stroke. Intensified efforts aimed at identifying and treating MetS, especially among middle-aged individuals, may be warranted to avert stroke risk.


2006 ◽  
Vol 43 (2) ◽  
pp. 136-139 ◽  
Author(s):  
Altan Onat ◽  
Gülay Hergenç ◽  
Ahmet Karabulut ◽  
Serdar Türkmen ◽  
Yüksel Doğan ◽  
...  

2015 ◽  
Vol 63 (10) ◽  
pp. 1991-2000 ◽  
Author(s):  
Martí Juanola-Falgarona ◽  
Jordi Salas-Salvadó ◽  
Pilar Buil-Cosiales ◽  
Dolores Corella ◽  
Ramón Estruch ◽  
...  

2020 ◽  
Author(s):  
Bo Liu ◽  
Guanqun Chen ◽  
Ruijie Zhao ◽  
Dan Huang ◽  
Lixin Tao

Abstract Background: Metabolic syndrome (MetS) is a major risk factor for cardiovascular diseases. The objective of the study was to evaluate the updated prevalence of MetS and provide a comprehensive illustration of the possible temporal changes in MetS prevalence in China from 2011 to 2015.Methods: The data for this study are from the 2011 and 2015 waves of the China Health and Retirement Longitudinal Study (CHARLS). CHARLS is a nationally representative survey targeting populations aged 45 and above from 28 provinces in mainland China. A total of 11847 and 13013 participants were eligible for data analysis at the two time points.Results: The estimated prevalence of MetS in 2015 was 20.41% (95% CI: 19.02%-21.8%) by the ATP III criteria, 34.77% (95% CI: 33.12%-36.42%) by the International Diabetes Federation (IDF) criteria, 39.68% (95% CI: 37.88%-41.47%) by the revised ATP III criteria, and 25.55% (95% CI: 24.19%-26.91%) by the Chinese Diabetes Society (CDS) criteria. The prevalence was higher among women and elderly adults and in urban and northern populations. Furthermore, the trends in the prevalence decreased significantly between 2011 and 2015 by the ATP III, revised ATP III and CDS criteria. However, trends increased significantly from 2011 to 2015 by the IDF criteria.Conclusions: In China, elderly women living in northern urban areas should receive more attention. Notably, temporal changes in the prevalence of MetS varied somewhat according to different criteria.


2021 ◽  
Vol 5 (Supplement_2) ◽  
pp. 171-171
Author(s):  
Esti Nurwanti ◽  
Chyi-Huey Bai

Abstract Objectives In this cross-sectional community-based study, we explored the relationship between TMAO and BMI with metabolic syndrome among middle-aged and elderly adults in Taiwan. Methods Population in this study were from a cross-sectional, community-based study in northern Taipei City, Taiwan. Eighty-six adults subject aged over 40 years (men and women) were enrolled. All subjects live near the Shin Kong Hospital. Body mass index (BMI) calculated based on body height and weight data. TMAO measured by enzyme-linked immunosorbent assay (ELISA) according to the manufactory's instruction. Metabolic syndrome was defined based on the 2005 revised National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III). The logistic regression, odds ratios (OR) and 95% confidence intervals (CIs) were calculated. Results This study reported that the metabolic syndrome group had higher TMAO levels (17.62 ng/mL) compare to participants without metabolic syndrome. In a multiple logistic regression, after adjusted with age, gender, weekly red meat consumption, log Hs-CRP, log choline, l-carnitine, and total body fat percentage, TMAO (adjusted OR = 5.89, 95% CI: 1.08–32.37) and BMI (adjusted OR = 1.39, 95% CI: 1.08–1.79) were more likely to increase metabolic syndrome risk. Conclusions TMAO and BMI have roles in increasing metabolic syndrome risk. TMAO associated with higher OR of metabolic syndrome than BMI. Therefore, these findings showed that TMAO is a potential biomarker to predict metabolic syndrome risk in middle-aged and elderly adults in Taiwan. Funding Sources Indonesia Endowment Fund for Education (LPDP-BUDI LN), the Ministry of Finance, and the Ministry of Research Technology Higher Education, Republic of Indonesia.


Sign in / Sign up

Export Citation Format

Share Document